Last reviewed · How we verify
Kratom 12g
At a glance
| Generic name | Kratom 12g |
|---|---|
| Sponsor | Christopher D. Verrico |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kratom 12g CI brief — competitive landscape report
- Kratom 12g updates RSS · CI watch RSS
- Christopher D. Verrico portfolio CI